Crossmark

Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

Crossref DOI link: https://doi.org/10.1007/s41669-024-00522-6

Published Online: 2024-09-17

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mirzayeh Fashami, Fatemeh https://orcid.org/0000-0003-0189-9065
Tarride, Jean-Eric https://orcid.org/0000-0003-2913-7580
Sadeghirad, Behnam https://orcid.org/0000-0001-9422-5232
Hariri, Kimia https://orcid.org/0000-0002-1071-5515
Peyrovinasab, Amirreza https://orcid.org/0009-0004-6100-3667
Levine, Mitchell https://orcid.org/0000-0002-9010-0886
License Information

Text and Data Mining valid from 2024-09-17

Version of Record valid from 2024-09-17
More Information

Article History

First Online: 17 September 2024